A placebo controlled randomized clinical trial of Crocus sativus L.(saffron) on depression and food craving among overweight women with mild to moderate depression
For readers interested in related wellness strategies, visit our top articles on Health.HealingWell.com
Related Stories Moderate coffee intake may support heart health, AHA says ACC introduces cardiogenic shock designation to improve heart attack care Planetary Health Diet lowers cardiovascular risk in older women Longer duration of GLP-1RA use was associated with greater risk reduction
It is clinical protocol supported by hard data showing that slower dose escalation dramatically reduces side effects
Research in animal models and population studies suggests GLP-1 receptor agonists may reduce dementia risk and improve cognitive function, but clinical trials are still ongoing
63 Considering that T2DM and MASLD can reciprocally cause and affect each other, and given liraglutides potential therapeutic characteristics for MASLD, which may be beneficial for anti-fibrosis, more aggressive use of higher doses may bring greater clinical benefits in some groups, such as those with higher-grade fibrosis with or without T2DM